全文获取类型
收费全文 | 5667篇 |
免费 | 374篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 173篇 |
妇产科学 | 160篇 |
基础医学 | 653篇 |
口腔科学 | 52篇 |
临床医学 | 982篇 |
内科学 | 1079篇 |
皮肤病学 | 43篇 |
神经病学 | 568篇 |
特种医学 | 89篇 |
外科学 | 623篇 |
综合类 | 59篇 |
一般理论 | 5篇 |
预防医学 | 775篇 |
眼科学 | 62篇 |
药学 | 364篇 |
中国医学 | 1篇 |
肿瘤学 | 321篇 |
出版年
2023年 | 39篇 |
2022年 | 31篇 |
2021年 | 181篇 |
2020年 | 111篇 |
2019年 | 166篇 |
2018年 | 201篇 |
2017年 | 128篇 |
2016年 | 172篇 |
2015年 | 159篇 |
2014年 | 196篇 |
2013年 | 297篇 |
2012年 | 463篇 |
2011年 | 463篇 |
2010年 | 256篇 |
2009年 | 195篇 |
2008年 | 336篇 |
2007年 | 326篇 |
2006年 | 355篇 |
2005年 | 386篇 |
2004年 | 287篇 |
2003年 | 312篇 |
2002年 | 226篇 |
2001年 | 58篇 |
2000年 | 45篇 |
1999年 | 54篇 |
1998年 | 39篇 |
1997年 | 46篇 |
1996年 | 37篇 |
1995年 | 29篇 |
1994年 | 21篇 |
1993年 | 32篇 |
1992年 | 44篇 |
1991年 | 32篇 |
1990年 | 31篇 |
1989年 | 25篇 |
1988年 | 25篇 |
1987年 | 26篇 |
1986年 | 22篇 |
1985年 | 20篇 |
1984年 | 28篇 |
1983年 | 27篇 |
1982年 | 16篇 |
1981年 | 18篇 |
1980年 | 9篇 |
1979年 | 10篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1974年 | 6篇 |
1973年 | 6篇 |
1971年 | 6篇 |
排序方式: 共有6048条查询结果,搜索用时 265 毫秒
1.
Sarah E. Sheppard Laura Elizabeth Anderson Cathryn Sibbald Colleen Cotton Elizabeth Bhoj Marissa J. Perman Leslie Castelo‐Soccio 《Pediatric dermatology》2019,36(6):1007-1009
Epidermolysis bullosa simplex (EBS) is a skin fragility disorder resulting from mutations of structural proteins in the epidermis. We provide a brief report of long‐term survival and reproduction in a mother with EBS due to keratin 5 (KRT5) c.1429G > A (p.E477K) mutation, which causes a particularly severe form of the disease. 相似文献
2.
3.
Emarene Kalaw Malcolm Lim Jamie R. Kutasovic Anna Sokolova Lucinda Taege Kate Johnstone James Bennett Jodi M. Saunus Colleen Niland Kaltin Ferguson Irma Gresshoff Mark Bettington Nirmala Pathmanathan Gary M. Tse David Papadimos Rajadurai Pathmanathan Gavin Harris Rin Yamaguchi Puay Hoon Tan Stephen Fox Sandra A. O’Toole Peter T. Simpson Sunil R. Lakhani Amy E. McCart Reed 《British journal of cancer》2020,123(11):1665
4.
5.
6.
7.
Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. 总被引:5,自引:0,他引:5
William D Leslie Colleen Metge Elizabeth A Salamon C Kin Yuen 《Journal of clinical densitometry》2002,5(2):117-130
The ease of measurement and the quantitative nature of bone mineral densitometry (BMD) is clinically appealing. Despite BMD's proven capability to stratify fracture risk, data indicate that clinical risk factors provide complementary information on fracture susceptibility that is independent of BMD. Methods to quantify fracture risk using both clinical and BMD variables would have great appeal for clinical decision-making. We describe a procedure for quantifying hip fracture risk (5-yr and remaining lifetime) based on (1) the individual's age alone (base model, assuming average clinical risk factors and bone density), (2) incorporation of multiple patient-specific clinical risk factor data in the base model, and (3) incorporation of both patient-specific clinical risk factor data and BMD results. 相似文献
8.
9.
10.
Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. 总被引:3,自引:3,他引:0 下载免费PDF全文
N. Nakhostine C. Ribuot D. Lamontagne R. Nadeau R. Couture 《British journal of pharmacology》1993,110(1):71-76
1. Vasodepressor responses to intravenous (i.v.) injection of bradykinin (BK) and des-Arg9-BK, a selective B1 kinin receptor agonist, were characterized following i.v. pretreatment with selective B1 ([Leu8]-des-Arg9-BK) and B2 (Hoe 140) kinin receptor antagonists in anaesthetized dogs. 2. Des-Arg9-BK (0.05-3.3 nmol kg-1) produced dose-dependent decreases in mean arterial blood pressure with a ED50 0.4 nmol kg-1. The vasodepressor effects evoked by des-Arg9-BK (0.6 nmol kg-1) and BK (0.2 nmol kg-1) were greater after i.v. and i.a. injections, respectively. 3. The vasodepressor response to BK (0.6 nmol kg-1) but not to des-Arg9-BK (0.6 nmol kg-1) was significantly (P < 0.001) blocked by pretreatment with the B2 receptor antagonist, Hoe 140. 4. The vasodepressor response to des-Arg9-BK (0.6 nmol kg-1) but not to BK (0.6 nmol kg-1) was significantly (P < 0.001) reduced by pretreatment with the selective B1 receptor antagonist, [Leu8]-des-Arg9-BK. Although both B1 and B2 receptor antagonists caused a transient fall in blood pressure, their inhibitory action was unlikely to be related to a desensitization mechanism. 5. Inhibition of prostaglandin synthesis with indomethacin prevented the vasodepressor response induced by arachidonic acid (1 mg kg-1, i.v.) but not that to BK or des-Arg9-BK (0.6 nmol kg-1). 6. These results suggest, firstly, that the vasodepressor responses to i.v. BK and des-Arg9-BK are mediated by the activation of B2 and B1 receptors, respectively; secondly, that prostaglandins are not involved in the vasodepressor responses to kinins.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献